Phase III TRIDENT trial: Radiation and temozolomide plus /- tumor treating fields in newly diagnosed glioblastoma.

被引:0
|
作者
Shi, Wenyin
Kleinberg, Lawrence
Jeyapalan, Suriya A.
Goldlust, Samuel Aaron
Nagpal, Seema
Reardon, David A.
Combs, Stephanie E.
Roberge, David
Nishigawa, Ryo
Glas, Martin
机构
[1] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Tufts Med Ctr, Boston, MA 02111 USA
[4] Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA
[5] Stanford Univ, Stanford, CA 94305 USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Harvard Med Sch, Boston, MA 02115 USA
[8] German Canc Consortium DKTK Core Ctr Heidelberg, Munich, Germany
[9] DKTK Partner Site Munich TUM, Munich, Germany
[10] McGill Univ, Montreal, PQ, Canada
[11] Saitama Med Univ, Saitama, Japan
[12] Univ Hosp Essen, Essen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS2580
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Phase 3 TRIDENT trial: Radiation and temozolomide plus /- Tumor Treating Fields in newly diagnosed glioblastoma
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S72 - S72
  • [2] EF-32 (TRIDENT): A pivotal randomized trial of radiation therapy concomitant with temozolomide plus /- Tumor Treating Fields (TTFields) in newly diagnosed glioblastoma.
    Shi, Wenyin
    Kleinberg, Lawrence
    Jeyapalan, Suriya A.
    Goldlust, Samuel A.
    Nagpal, Seema
    Combs, Stephanie E.
    Roberge, David
    Nishigawa, Ryo
    Grossman, Rachel
    Glas, Martin
    CANCER RESEARCH, 2021, 81 (13)
  • [3] PHASE 3 TRIDENT TRIAL: CONCOMITANT RADIATION THERAPY (RT) AND TEMOZOLOMIDE plus /- TUMOR TREATING FIELDS (TTFIELDS) IN NEWLY DIAGNOSED GLIOBLASTOMA
    Shi, Wenyin
    Kleinberg, Lawrence
    Jeyapalan, Suriya A.
    Goldlust, Samuel
    Nagpal, Seema
    Combs, Stephanie E.
    Roberge, David
    Nishigawa, Ryo
    Grossman, Rachel
    Glas, Martin
    NEURO-ONCOLOGY, 2020, 22 : 59 - 60
  • [4] RANDOMIZED PHASE II TRIAL OF TUMOR TREATING FIELDS PLUS RADIATION THERAPY PLUS TEMOZOLOMIDE COMPARED TO RADIATION THERAPY PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Limon, D.
    Bokstein, F.
    Blumenthal, D.
    Ben Harush, C.
    Ram, Z.
    Grossman, R.
    NEURO-ONCOLOGY, 2019, 21 : 86 - 86
  • [5] EF-32 (TRIDENT): A pivotal phase 3 randomized trial of concomitant radiation therapy and temozolomide plus /- Tumor Treating Fields (TTFields) in newly diagnosed glioblastoma
    Glas, M.
    Kleinberg, L.
    Jeyapalan, S.
    Goldlust, S.
    Nagpal, S.
    Combs, S.
    Roberge, D.
    Nishikawa, R.
    Reardon, D.
    Grossman, R.
    Shi, W.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S97 - S98
  • [6] Scalp-sparing radiation with concurrent temozolomide and tumor treating fields (SPARE) for patients with newly diagnosed glioblastoma.
    Miller, Ryan C.
    Song, Andrew Jehyun
    Ali, Ayesha
    Bar-Ad, Voichita C.
    Martinez, Nina Leyson
    Glass, Jon
    Alnahhas, Iyad
    Andrews, David W.
    Judy, Kevin
    Evans, James J.
    Farrell, Christopher
    Werner-Wasik, Maria
    Chervoneva, Inna
    Ly, Michele
    Palmer, Joshua David
    Liu, Haisong
    Shi, Wenyin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Randomized Phase II trial of Tumor Treating Fields plus radiation therapy plus temozolamide compared to radiation therapy plus temozolomide in patients with newly diagnosed glioblastoma
    Grossman, Rachel
    Limon, Dror
    Bokstein, Felix
    Ben Harosh, Carmit
    Ram, Zvi
    CANCER RESEARCH, 2019, 79 (13)
  • [8] STANDARD OF CARE TEMOZOLOMIDE CHEMOTHERAPY ± TUMOR TREATING FIELDS (TTFIELDS) IN NEWLY DIAGNOSED GLIOBLASTOMA. FINAL RESULTS OF THE PHASE III EF-14 CLINICAL TRIAL
    Stupp, R.
    Ram, Z.
    NEURO-ONCOLOGY, 2017, 19 : 15 - 15
  • [9] PHASE III TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) TOGETHER WITH TEMOZOLOMIDE (TMZ) COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Farber, Ori
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2013, 15 : 76 - 77
  • [10] Clinical efficacy of tumor-treating fields for newly diagnosed glioblastoma.
    Liu, Yang
    Richardson, Margie
    Warren, Kwanza
    Strawderman, Myla S.
    Mohile, Nimish
    Milano, Michael T.
    Walter, Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)